| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Ascendis Pharma A/S (NASDAQ: ASND)
ASND Technical Analysis
4
| As on 9th Jun 2023 ASND STOCK Price closed @ 92.66 and we RECOMMEND Sell for LONG-TERM with Stoploss of 105.17 & Strong Sell for SHORT-TERM with Stoploss of 120.65 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ASNDSTOCK Price
| Open | 92.21 | Change | Price | % |
| High | 93.07 | 1 Day | 0.45 | 0.49 |
| Low | 91.50 | 1 Week | 2.91 | 3.24 |
| Close | 92.66 | 1 Month | 14.30 | 18.25 |
| Volume | 100162 | 1 Year | -39.73 | -30.01 |
| 52 Week High 139.32 | 52 Week Low 69.96 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ASND Daily Charts |
ASND Intraday Charts |
Whats New @ Bazaartrend |
ASND Free Analysis |
|
|
ASND Important Levels Intraday
| RESISTANCE | 95.69 |
| RESISTANCE | 94.72 |
| RESISTANCE | 94.12 |
| RESISTANCE | 93.52 |
| SUPPORT | 91.80 |
| SUPPORT | 91.20 |
| SUPPORT | 90.60 |
| SUPPORT | 89.63 |
ASND Forecast May 2024
| 4th UP Forecast | 147.96 |
| 3rd UP Forecast | 130.23 |
| 2nd UP Forecast | 119.26 |
| 1st UP Forecast | 108.3 |
| 1st DOWN Forecast | 77.02 |
| 2nd DOWN Forecast | 66.06 |
| 3rd DOWN Forecast | 55.09 |
| 4th DOWN Forecast | 37.36 |
ASND Weekly Forecast
| 4th UP Forecast | 115.86 |
| 3rd UP Forecast | 108.42 |
| 2nd UP Forecast | 103.82 |
| 1st UP Forecast | 99.22 |
| 1st DOWN Forecast | 86.10 |
| 2nd DOWN Forecast | 81.50 |
| 3rd DOWN Forecast | 76.90 |
| 4th DOWN Forecast | 69.46 |
ASND Forecast2024
| 4th UP Forecast | 249.73 |
| 3rd UP Forecast | 199.36 |
| 2nd UP Forecast | 168.22 |
| 1st UP Forecast | 137.08 |
| 1st DOWN Forecast | 48.24 |
| 2nd DOWN Forecast | 17.1 |
| 3rd DOWN Forecast | -14.04 |
| 4th DOWN Forecast | -64.41 |
Ascendis Pharma A/S ( NASDAQ USA Symbol : ASND )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ASND Business Profile
Ascendis Pharma A/S, a biopharmaceutical company, develops therapeutics for unmet medical needs. The company develops TransCon growth hormone, which completed Phase III clinical trials for growth hormone deficiency. It also develops TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for achondroplasia. In addition, the company develops preclinical studies in the field of oncology for potential product candidates and evaluate systemic and localized delivery systems using its TransCon technologies. The company was incorporated in 2006 and is headquartered in Hellerup, Denmark. Address: Tuborg Boulevard 12, Hellerup, Denmark, 2900
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service